These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20591905)

  • 1. Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients.
    Johannes M; Brase JC; Fröhlich H; Gade S; Gehrmann M; Fälth M; Sültmann H; Beissbarth T
    Bioinformatics; 2010 Sep; 26(17):2136-44. PubMed ID: 20591905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recursive gene selection based on maximum margin criterion: a comparison with SVM-RFE.
    Niijima S; Kuhara S
    BMC Bioinformatics; 2006 Dec; 7():543. PubMed ID: 17187691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel feature selection approach for biomedical data classification.
    Peng Y; Wu Z; Jiang J
    J Biomed Inform; 2010 Feb; 43(1):15-23. PubMed ID: 19647098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue.
    Chen Z; Li J; Wei L
    Artif Intell Med; 2007 Oct; 41(2):161-75. PubMed ID: 17851055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor classification ranking from microarray data.
    Hewett R; Kijsanayothin P
    BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S21. PubMed ID: 18831787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARSVM: a class association rule-based classification framework and its application to gene expression data.
    Kianmehr K; Alhajj R
    Artif Intell Med; 2008 Sep; 44(1):7-25. PubMed ID: 18586476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GMM-IG framework for selecting genes as expression panel biomarkers.
    Wang M; Chen JY
    Artif Intell Med; 2010; 48(2-3):75-82. PubMed ID: 20004087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SVM-T-RFE: a novel gene selection algorithm for identifying metastasis-related genes in colorectal cancer using gene expression profiles.
    Li X; Peng S; Chen J; Lü B; Zhang H; Lai M
    Biochem Biophys Res Commun; 2012 Mar; 419(2):148-53. PubMed ID: 22306013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliable gene signatures for microarray classification: assessment of stability and performance.
    Davis CA; Gerick F; Hintermair V; Friedel CC; Fundel K; Küffner R; Zimmer R
    Bioinformatics; 2006 Oct; 22(19):2356-63. PubMed ID: 16882647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor.
    Kun Y; How LC; Hoon TP; Bajic VB; Lam TS; Aggarwal A; Sze HG; Bok WS; Yin WC; Tan P
    Hum Mol Genet; 2003 Dec; 12(24):3245-58. PubMed ID: 14570715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recursive fuzzy granulation for gene subsets extraction and cancer classification.
    Tang Y; Zhang YQ; Huang Z; Hu X; Zhao Y
    IEEE Trans Inf Technol Biomed; 2008 Nov; 12(6):723-30. PubMed ID: 19000951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differential gene expression for microarray data using recursive random forest.
    Wu XY; Wu ZY; Li K
    Chin Med J (Engl); 2008 Dec; 121(24):2492-6. PubMed ID: 19187584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SVM-RFE with MRMR filter for gene selection.
    Mundra PA; Rajapakse JC
    IEEE Trans Nanobioscience; 2010 Mar; 9(1):31-7. PubMed ID: 19884101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene extraction for cancer diagnosis by support vector machines--an improvement.
    Huang TM; Kecman V
    Artif Intell Med; 2005; 35(1-2):185-94. PubMed ID: 16026974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-class cancer subtype classification based on gene expression signatures with reliability analysis.
    Fu LM; Fu-Liu CS
    FEBS Lett; 2004 Mar; 561(1-3):186-90. PubMed ID: 15013775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification.
    Nam H; Chung BC; Kim Y; Lee K; Lee D
    Bioinformatics; 2009 Dec; 25(23):3151-7. PubMed ID: 19783829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parsimonious threshold-independent protein feature selection method through the area under receiver operating characteristic curve.
    Wang Z; Chang YC; Ying Z; Zhu L; Yang Y
    Bioinformatics; 2007 Oct; 23(20):2788-94. PubMed ID: 17878205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.